Is MOTS-c Legal in Virginia?
HealthRX.com
No federal record makes MOTS-c clearly legal in Virginia
See the public record for MOTS-c
At a glance
- Federal approval / None; no USP monograph, not a component of an approved drug [1]
- FDA list for pharmacies and physicians / Not listed; not in any of the three interim categories (updated May 14, 2026) [2][6]
- FDA list for outsourcing facilities / Not listed (updated March 21, 2025) [3]
- FDA safety view / No human exposure data; injectable peptide, immunogenicity concern [7]
- Advisory committee / Voted July 23, 2026 in favor of listing; advice only [8][4]
- HHS draft policy / October 2026, MOTS-c acetate by injection, with conditions [4][5]
- Sport / Prohibited at all times by WADA, S4.4.1 [9]
Is MOTS-c FDA-approved?
No. FDA's July 2026 review found no USP or National Formulary monograph for MOTS-c, no listing in the European or Japanese pharmacopeias, and no EMA-authorized product, and MOTS-c is not a component of any approved drug [1].
Can a pharmacy compound it?
Under the federal rules for state-licensed pharmacies and physicians, a bulk substance may be compounded only if it complies with a USP or National Formulary monograph, is a component of an FDA-approved drug, or appears on FDA's bulks list [6]. MOTS-c meets none of those conditions [1][2].
It is not on the bulks list and appears in none of the three interim categories on FDA's page for state-licensed pharmacies and physicians (updated May 14, 2026), so the category 1 policy of generally not taking action against compounders does not cover it [2][6]. It is also absent from FDA's list for outsourcing facilities (updated March 21, 2025) [3]. FDA's page on bulk substances that may raise significant safety risks lists MOTS-c in its "nominated but withdrawn" table, noting no human exposure data by any route and a risk of immunogenicity from aggregation and peptide impurities; removal from category 2 was not a finding that it is safe [7].
Did the 2026 advisory vote or the HHS draft change that?
No. The Pharmacy Compounding Advisory Committee voted on July 23, 2026 in favor of adding MOTS-c to the bulks list, against FDA staff's recommendation. The vote is advice only, MOTS-c is not on the list, and listing takes formal rulemaking [8][4]. FDA staff had proposed against listing, citing no human safety or effectiveness data and no animal toxicity studies [1].
Separately, HHS filed a draft enforcement-discretion policy on October 28, 2026 (Federal Register document 2026-22192) naming MOTS-c among six peptides and covering MOTS-c acetate by subcutaneous or intramuscular injection [4][5]. HHS says it does not intend to take enforcement action against a state-licensed pharmacy, federal facility or licensed physician compounding it if the policy's conditions are met. Examples include a single active ingredient, a patient-specific prescription, and a manufacturer registered with FDA that supplies a certificate of analysis [4][5]. The notice says it establishes no rights and is not binding on HHS or the public, and HHS may revisit it, for example if a safety signal or product quality issue arises. It is not an approval and does not put MOTS-c on any list [4]. Compounded drugs are not FDA-approved, and FDA does not review their safety, effectiveness or quality before marketing [4].
What does this mean for Virginia?
Virginia has its own medical-practice and licensure statutes [10]. The federal records above address FDA approval and federal compounding policy, and they do not settle whether Virginia permits a particular MOTS-c prescription or compounding arrangement.
Questions worth asking
Frequently asked questions
Is MOTS-c FDA-approved?
Is MOTS-c legal in Virginia?
Can a Virginia pharmacy compound MOTS-c?
Is MOTS-c banned in sport?
References
Show all 10 referencesHide references
- U.S. Food and Drug Administration.
- U.S. Food and Drug Administration.
- U.S. Food and Drug Administration.
- Official web page.
- Official web page.
- Bulk Drug Substances Used in Compounding of the FD&C Act | FDA.
- Certain Bulk Drug Substances for Use in Compounding that May Present Significant Safety Risks | FDA.
- U.S. Food and Drug Administration.
- World Anti-Doping Agency.
- Code of Virginia Code - Chapter 29. Medicine and Other Healing Arts.